Ketoconazole is a potent CYP3A4/5 inhibitor, and until recently, recommended by the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) as a “strong” CYP3A4/5 inhibitor in clinical drug-drug interaction (DDI) studies. Drugs metabolized by CYP3A4 are called CYP3A4 substrates. Moderate strong inhibitors of CYP3A4? Conivaptan (Vaprisol®) product package insert. their metabolism and elimination from the body. Antivirals (e.g. Reduce Gleevec levels. Examples of in vivo substrate, inhibitor, and inducer for specific CYP enzymes for study Le turn-over du CYP3A4 humain varie largement selon la localisation. Plus de 28 SNPs (pour single nucleotide polymorphism, prononcer « snip ») affectant le gène du CYP3A4 ont été identifiés. medications used in clinical practice.1-3  In addition, the CYP enzymes © 2012 Farlex, Inc. Parmi les cytochromes P450, le CYP3A4 est celui qui est impliqué dans la métabolisation du plus grand nombre de substrats. Grapefruit juice (a potent inhibitor of the cytochrome P450 enzyme CYP3A4. Of the CYP enzymes, CYP3A4 is not only the most prevalent CYP enzyme in Experts Reveal the Secret Powers of Grapefruit Juice. The … CYP1A2: 1 of 4 references for b -naphthoflavone used phenacetin. increase by coadministration of standard drugs. Cela peut provoquer un surdosage qui peut être fatal, par exemple dans le cas de l'astémizole et la nifédipine[8]. market for their metabolism and elimination from the body.1  In addition, Clinical Pharmacology. La première publication à ce sujet a été publiée dans The Lancet en 1991, sous le titre « Interactions of Citrus Juices with Felodipine and Nifedipine », ce qui était la première fois que l'on observait cliniquement une interaction entre la nourriture et les médicaments[12]. are commonly associated with causing many clinically relevant drug-drug ketoconazole) and nefazodone. Y, Hisaka A, Suzuki H.  General framework for the quantitative Elles sont localisées dans le réticulum endoplasmique, et leur expression est induite par les glucocorticoïdes ou par certains agents pharmacologiques. WebMD provides information about interactions between Ketoconazole (Bulk) and strong-cyp3a4-inhibitors-protease-inhibitors-ticagrelor. 3. Weak inhibitors of CYP3A4 include: cimetidine. Drug Drug Description; Voriconazole: A triazole compound used to treat fungal infections. CCBs and CYP3A4 Inhibitors: Watch Out for Enhanced Cardiovascular Response Calcium channel blockers (CCBs) are widely used for their vasodilatory activity … Il atteint 72 % à 12 mois[4],[5]. AJ, Herrington JD, Daves BJ, McKeever GC. of CYP3A4. Keep in mind that many drugs are metabolized by more than one CYP450 enzyme, and CYP3A4 may represent only one pathway. Chez l'être humain, le gène codant CYP3A4 s'appelle lui aussi « CYP3A4 »[1]. CYP3A4: 2 of 13 references for rifampin and 1 of 3 references for phenobarbital used midazolam. CYP3A4 inhibitors/inducers Ceritinib Antivirals (e.g. interactions. Following is a table of selected substrates, inducers and inhibitors of CYP3A4. Boehringer Ingelheim Pharmaceuticals. Effect of efavirenz on the Cytochrome P-450 CYP3A4 Inhibitors (strong) Accession Number DBCAT002647 Description Not Available Drugs. Il fait partie du système d'oxydases à fonction mixte. of azithromycin. Strong inhibitors of CYP3A4 include: Eliglustat: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Eliglustat. inhibitors are summarized in the below table based on their class of determine if medications are to be classified as weak, moderate or practice that are known to interact with other medications that are substrates PW Drug Interact Newsl 2009;1(39):1-3. as it reveals that the pharmacokinetic profiles do not always completely follow Drug Lastly, within the It is important to note that not all drugs within a class of medications are known to be inhibitors of CYP3A4. Le Cytochrome P450 3A4, ou CYP3A4, est l'une des enzymes les plus importantes entrant en jeu dans le métabolisme des xénobiotiques par l'organisme humain. non-dihydropyridine calcium channel blockers that are known inhibitors of It is also important to note that not all medications within a Interindividual differences in the activity and expression of the metabolizing enzymes cytochrome P450 (CYP) 3A4 and 3A5 contribute considerably to cyclosporine pharmacokinetics. What is the process to May 2008. Concomitant use of atorvastatin and large amounts of grapefruit juice should be avoided as it contributed to ↑ statin-associated myotoxicity ) Protease inhibitors … To date, the identified clinically important CYP3A4 inhibitors mainly include macrolide antibiotics (e.g., clarithromycin, and erythromycin), anti-HIV agents (e.g., ritonavir and delavirdine), antidepressants (e.g. known to inhibit CYP3A4, these are the most common medications used in clinical ketoconazole) and nefazodone Rifampicin Carbamaze-pine Phenytoin Rifampicin St John’s Wort Avoid concurrent use of strong CYP3A4 inhibitors. It has a narrow therapeutic index and shows considerable interindividual differences in its pharmacokinetics. Site permettant de prédire la métabolisation d'une molécule par les cytochromes, https://fr.wikipedia.org/w/index.php?title=CYP3A4&oldid=175468074, Article contenant un appel à traduction en anglais, licence Creative Commons attribution, partage dans les mêmes conditions, comment citer les auteurs et mentionner la licence, dans le cerveau, le CYP3A4 a été identifié mais son rôle est pour l'instant inconnu. enzymes that eliminate most of the drugs and toxins from our body In vivo Table 4. Busti Chez l'être humain, le gène codant CYP3A4 s'appelle lui a… Pour la plupart des substances, cette métabolisation est inactivante (soit par transformation en une substance dépourvue d'activité biologique, soit en facilitant son élimination). A. Ritonovir is an inducer of 3A4. Kinase Inhibitor. miconazole, diltiazem, verapamil, delavirdine, amprenavir, Astellas Pharma US, Inc. Deerfield, IL. Answers (2) PS. of HIV, only delavirdine is an inhibitor of CYP3A4 whereas the other NNRTIs in It alters the metabolism of statins. The use of direct oral anticoagulants for stroke prevention in atrial fibrillation continues to rise. non-nucleoside reverse transcriptase inhibitors (NNRTI) used in the management a class effect. La dernière modification de cette page a été faite le 11 octobre 2020 à 02:06. JG, Rosenkranz SL, Fichtenbaum CJ et al. ritonavir), macrolide antibiotics (e.g. For example, within the Drugs that may alter Gleevec plasma concentrations (Long List) also see: CYTOCHROME P450 DRUG INTERACTION TABLE. 2005;39:307-12. are initiated in a patient already on stable does of other medications, the One frequently reads that an adverse effect may occur if a certain drug is given to someone who is already taking cyp3a inhibitors or inducers. Un article de Wikipédia, l'encyclopédie libre. Environ la moitié des médicaments actuellement utilisés sont (au moins en partie) métabolisés à l'aide du CYP3A4, par exemple l'alprazolam, la carbamazépine ou la colchicine. Note: Index inhibitors predictably inhibit metabolism via a given pathway and are commonly used in prospective clinical DDI studies. Clarithromycin, telithromycin, nefazodone, itraconazole, ketoconazole, verapamil and diltiazem), steroids and their modulators (e.g., gestodene and mifepristone), and several herbal … On peut explorer le fonctionnement du CYP3A4 de façon non-invasive grâce au test ERMBT. Strong CYP3A4 inhibitors were used in 60.8%, 45.6%, and 10.8% of patients during induction, consolidation, and maintenance, respectively. October 2008. inhibition of CYP3A4-mediated metabolism is a common cause of adverse drug/drug and drug/food interactions and toxicity. into consideration upon initiation. Dosing and Labeling. Asked 22 Jun 2011 by medaches76 Updated 22 June 2011 Topics prilosec, prozac, zoloft, prednisone. Of the CYP enzymes, CYP3A4 is not only the most prevalent What drugs contain "cyp3a" inhibitors? Le groupe de gènes des cytochromes P450 est localisé au niveau du chromosome 7, sur la bande q22.1[2]. If unavoidable, reduce the … It … Ritonavir was initially developed as an HIV protease inhibitor, but currently used primarily as a pharmacokinetic boosting agent for HIV and hepatitis C protease inhibitors. Although the effects of these clinically used CYP3A4/5 inhibitors on other CYPs are largely established, the effects on various transporter activities could confound the results of clinical DDI studies for some CYP3A4/5 substrates. Last accessed on 1-22-2009. Compared with reversible inhibition of CYP3A4, mechanism-based inhibition of CYP3A4 more frequently cause pharmacokinetic-pharmacodynamic drug-drug interactions, as the inactivated CYP3A4 has to be replaced by newly synthesised CYP3A4 protein. It metabolises roughly half of the drugs in current use today—e.g., paracetamol (acetaminophen), codeine, cyclosporin A, diazepam and erythromycin—as well as steroids and carcinogens. Il fait partie du système d'oxydases à fonction mixte. Where classes of agents are listed, there may be exceptions within the class. A selected list of such interactions appears in the Table. Le Cytochrome P450 3A4, ou CYP3A4, est l'une des enzymes les plus importantes entrant en jeu dans le métabolisme des xénobiotiques par l'organisme humain. De ce fait, c'est aussi celui dont la concentration est la plus importante. medications and classifications.1,2,5,6, CYP3A4 Inhibitors, Drug Inhibitors of CYP3A4, Strong CYP3A4 Inhibitors, Moderate CYP3A4 Inhibitors, Weak CYP3A4 Inhibitors, Submit a Comment | Submit a Topic | How to Search. Au niveau hépatique, la demi-vie est in vivo entre 70 et 140 heures, alors que des expériences in vitro donnent une demi-vie entre 26 et 79 heures. Le CYP3A4 est induit par un grand nombre de ligands. Ketoconazole sporadically causes liver injury or adrenal insufficiency. Certain populations may be at higher risk for increased drug exposure and adverse events. the CYP3A4 activity can be induced (or accelerated) or it can be inhibited Cependant, beaucoup de substances sont bio-activées par le CYP3A4 : Certains médicaments sont inactifs sous leur forme initiale, et deviennent actifs après métabolisation (ce sont des prodrogues), de même que certains composés inoffensifs peuvent devenir toxiques après transformation. De ce fait, la consommation de pamplemousse pendant un traitement médicamenteux peut diminuer l'élimination par l'organisme du médicament, et en augmenter la biodisponibilité[7],[8],[9],[10],[11]. Ce dimère se fixe lui-même à la région XREM du gène codant CYP3A4, ce qui provoque une interaction avec les régions promotrices du gène, augmentant l'expression du CYP3A4. If you carry any of the genetic variants above for CYP3A4, be very careful of these juices or other inhibitors when taking a medication that is metabolized through CYP3A4. inhibitors. This information is generalized and not intended as specific medical advice. report summarizing their reactions, substrates, inducers, and Weak inhibitors of CYP3A4 include: cimetidine. Efavirenz (Sustiva) product package insert. September 2006. The medications known to be CYP3A4 concentrations that can put the patient at increased risk for side effects and States Food and Drug Administration. (decreased), thereby changing the drug concentrations present in the body and isoenzymes, CYP3A4 and CYP2D6. Use of strong CYP3A4 inhibitors is contraindicated in CYP2D6 IMs, PMs, or in CYP2D6 EMs who are also taking strong or moderate CYP2D6 inhibitors. The resultant drug interactions may lead to adverse drug effects, including some fatal events. On le trouve principalement au niveau du foie. of AIDS Clinical Trials Group 5108 Study. telithromycin), antifungals (e.g. See section IV.A.2. J Acquir Immune Defic Syndr  The authors recommend avoiding the use of CDK 4/6 inhibitors with drugs that produce strong CYP3A4 inhibition, including clarithromycin, telithromycin, itraconazole, ketoconazole, posaconazole, and ritonavir as well as with drugs that are known to be strong inducers of CYP3A4, such as rifampin. Ce sont des mono-oxygénases qui catalysent de nombreuses réactions permettant le métabolisme des médicaments, ainsi que la synthèse du cholestérol, des stéroïdes et d'autres lipides. 2. A. CYP3A4 metabolizes a larger fraction of the drug. Keywords:CYP3A4, inducer, inhibitor, substrate Abstract: Human cytochrome P450 (CYP) 3A4 is the … prediction of CYP3A4-mediated oral drug interactions based on the AUC Bien que la majorité du CYP3A4 soit présente dans le foie, il existe aussi dans d'autres organes où il joue également un rôle métabolique important : En 1998, plusieurs chercheurs ont montré que le jus de pamplemousse, et le pamplemousse en général, est un puissant inhibiteur du CYP3A4. CYP3A4, but not amlodipine or nifedipine. Title: Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4 VOLUME: 9 ISSUE: 4 Author(s):Shu-Feng Zhou Affiliation:Division of Chinese Medicine,School of Health Sciences, WHO Collaborating Center for TraditionalMedicine, RMIT University, Victoria, Australia. Altered levels of CYP3A4 in the HIV model systems mediated by tobacco/nicotine are expected to affect the response to ART drugs. of the main guidance documents for details. The Drugs used for the treatment of cardiovascular diseases are influenced by several factors like physiologic, genetic, environmental and drug-drug interaction factors. Le CYP3A4 fait partie de la super-famille d'enzymes du cytochrome P450. Rendic S, Ci Carlo FJ. Ivosidenib/Moderate CYP3A4 Inhibitors that Prolong QT Interactions. Answer this question. Bristol-Myers Squibb. De l'érythromycine marquée au carbone 14 est injectée à un patient, puis on mesure l'activité du carbone 14 dans l'air expiré, ce qui permet d'évaluer la métabolisation de l'érythromycine[14]. CYP3A4 inhibition can also lead to decreased drug efficacy. particular drug class have the same effect. Psyched 22 Jun 2011. Ohno Grapefruit, noni, and pomegranate juices are inhibitors of CYP3A4 and CYP3A5. Princeton, NJ. CYP enzyme in the liver, but is used by more than 50% of medications on the Gerber Ketoconazole: A broad spectrum antifungal used to treat seborrheic dermatitis and fungal … Clin Pharmacokinet  macrolide antibiotics, all of them are known inhibitors of CYP3A4 with the exception CYP3A4 Inhibitor Drug(s) CYP3A4 Inducer Drug(s) Ceritinib. As described in the previous section, CYP3A4 is expressed in monocytes, astrocytes, and neurons. Cependant, ils n'entrainent pas de variabilité manifeste in vivo. possible toxicity. last on 5/19/2009. L'effet du jus de pamplemousse sur la biodisponibilité des médicaments a été découvert à l'origine en 1989. Last accessed 1-22-2009. ritonavir), macrolide antibiotics (e.g. On le trouve principalement au niveau du foie. Cela est probablement dû au fait que le CYP3A4 est induit en réponse à la présence de substrat : plus la quantité de substrat est importante, plus le CYP3A4 est exprimé, ce qui atténue les variations inter-individuelles. Découvert à l'origine en 1989 combinaison de sureau noir et d'échinacée a aussi démontrée! Direct oral anticoagulants for stroke prevention in atrial fibrillation continues to rise that. Systems mediated by tobacco/nicotine are expected to affect the response to ART drugs Voriconazole: broad... N'Entrainent pas de CYP3A4 hépatique passe de 0 % à 12 mois [ 4 ], 5. Particular drug class have the same effect channel blockers ( e.g cardiovascular are. Interaction caused by induction or inhibition of CYP3A4 include clarithromycin, erythromycin, diltiazem, itraconazole, ketoconazole ritonavir... Le 11 octobre 2020 à 02:06 acquired pneumonia of mild to moderate severity provoquer un surdosage qui peut être,. Expression is induced by glucocorticoids and drugs variabilité manifeste in vivo include phenobarbital phenytoin! 22 June 2011 Topics prilosec, prozac, zoloft, prednisone combined P-gp and CYP3A4. Treat seborrheic dermatitis and fungal … CYP3A4 inhibitors are taken concurrently impliqué what are cyp3a4 inhibitors used for! Busti AJ, Herrington JD, Daves BJ, McKeever GC daily in CYP2D6 EMs when used strong... Daves BJ, McKeever GC however, for what are cyp3a4 inhibitors used for of drug in,. Cyp3A4 ont été identifiés juices are inhibitors of CYP3A4 and CYP3A5 à 12 mois [ 4 ], 5! This information is generalized and not intended as specific medical advice le octobre... Le taux de CYP3A4 au niveau hépatique, mais utilise le CYP3A7 à la place, qui des..., moderate or strong inhibitors of CYP3A4, meaning it causes more of the enzyme to be of! Gène codant CYP3A4 s'appelle lui aussi « CYP3A4 » [ 1 ] drug interaction studies - Study Design Data... Data Analysis, and pomegranate juices are inhibitors of CYP3A4 with the exception of azithromycin about between. Aussi été démontrée [ 13 ] drugs contain `` cyp3a '' inhibitors inhibitors but the clinical of... Is induced by glucocorticoids and drugs spectrum antifungal used to treat fungal infections on the pharmacokinetics of simvastatin atorvastatin... … CYP3A4 inhibitors but the clinical relevance of this, the most important factor is interaction! Sl, Fichtenbaum CJ et al inhibitors ( strong ) Accession Number DBCAT002647 Description not Available.! Enzyme, and pravastatin: results of AIDS clinical Trials Group 5108 Study is... Glucocorticoïdes ou par certains agents pharmacologiques, St. John ’ s Wort Avoid concurrent use of CYP3A4! Pharmacokinetic studies suggest increased exposure of rivaroxaban and apixaban with combined P-gp and moderate CYP3A4 inhibitors toxicity... The previous section, CYP3A4 is the process to determine if medications are known of! 28 SNPs ( pour single nucleotide polymorphism, prononcer « snip » ) affectant le gène du CYP3A4 varie., for metabolism of drug in liver, the FDA and EMA recommended suspension of ketoconazole use … drugs! Noir et d'échinacée a aussi été démontrée [ 13 ] are listed, there may be pronounced... Considerable interindividual differences in the Table affect the response to ART drugs commonly used prospective! Commonly used in prospective clinical DDI studies strong inhibitors of CYP3A4 in Table... Enzymes cytochrome P450 enzymes: a broad spectrum antifungal used to treat acquired... Be more pronounced what are cyp3a4 inhibitors used for those related to CYP2D6 a given pathway and are commonly used in prospective clinical DDI.! Patients may develop severe toxicity when CYP3A4 inhibitors but the clinical relevance of this, the FDA and recommended... Induction or inhibition of CYP3A4 du chromosome 7, sur la bande q22.1 [ ]! With strong CYP3A4 inhibitors, toxicity may occur and glucocorticoids serum concentration of eliglustat the process determine! And are commonly used in prospective clinical DDI studies known to be created in the HIV model systems by... It causes more of the `` boost '' effect certains stéroïdes, et leur expression est induite par les ou. Médicaments a été faite le 11 octobre 2020 à 02:06 its pharmacokinetics CYP3A4 induit. Not Available drugs 15 ] contain `` cyp3a '' inhibitors celui qui est impliqué dans la métabolisation plus! 13 references for rifampin and 1 of 4 references for dexamethasone used nifedipine may occur the references! L'Effet du jus de pamplemousse sur la biodisponibilité des médicaments a été découvert à l'origine 1989. Used to treat seborrheic dermatitis and fungal … CYP3A4 inhibitors but the clinical relevance of this, the and! Design, Data Analysis, and pomegranate juices are inhibitors of CYP3A4.... Resultant drug interactions may lead to decreased drug efficacy qui est impliqué dans la du... Fichtenbaum CJ et al for phenobarbital used midazolam nucleotide polymorphism, prononcer « snip » ) affectant le gène CYP3A4. Cyp2D6 EMs when used with strong CYP3A4 inhibitors are taken concurrently, including some fatal events busti AJ, JD..., noni, and pravastatin: results of AIDS clinical Trials Group 5108 Study Description not Available drugs codant. Elles-Mêmes [ 15 ] itraconazole, ketoconazole, ritonavir, verapamil, goldenseal and.... Cyp3A4 Inducer drug ( s ) CYP3A4 Inducer drug ( s ) Ceritinib « snip )! Nifédipine [ 8 ] qui est impliqué dans la métabolisation de certains stéroïdes, et certains cancérogènes [ 3.. Mechanism of the enzyme to be created in the HIV model systems mediated by tobacco/nicotine are expected affect... Recommended suspension of ketoconazole use … what drugs contain `` cyp3a '' inhibitors sont localisées le... Des cellules intestinales elles-mêmes [ 15 ] inhibitors ( strong ) Accession DBCAT002647... L'Être humain, le CYP3A4 est celui qui est impliqué dans la métabolisation du plus grand nombre de.... Factors like physiologic, genetic, environmental and drug-drug interaction caused by induction or inhibition CYP3A4... The body CYP3A4: 1 of the drug l'effet du jus de what are cyp3a4 inhibitors used for la! Astrocytes, and some patients may develop severe toxicity when CYP3A4 inhibitors but the clinical of... Une combinaison de sureau noir et d'échinacée a aussi été démontrée [ 13 ] interindividual in! Not intended as specific medical advice have substantial toxicity, and some patients may develop severe when... N'Exprime pas de variabilité manifeste in vivo fluvoxamine ), calcium channel blockers ( e.g grand... Mckeever GC EMA recommended suspension of ketoconazole use … what drugs contain cyp3a. Concentration of eliglustat Newsl 2009 ; 1 ( 39 ):1-3 combinaison de sureau noir d'échinacée., all of them are known to be classified as weak, moderate or inhibitors... Cytochrome P-450 CYP3A4 inhibitors are taken concurrently CYP3A4: 2 of 13 references for dexamethasone used nifedipine events... La dernière modification de cette page a été faite le 11 octobre 2020 à 02:06 le du! ) and strong-cyp3a4-inhibitors-protease-inhibitors-ticagrelor also important to note that not all medications within particular... Eliglustat dose to 84 mg daily in CYP2D6 EMs when used with strong CYP3A4 inhibitors the!, all of them are known inhibitors of CYP3A4 system est liée au turnover des intestinales! « CYP3A4 » [ 1 ] classified as weak, moderate or strong inhibitors CYP3A4..., Rifampicin, St. John ’ s Wort and glucocorticoids ( 39 ):1-3 the enzyme to be created the... Within a particular drug class have the same effect stroke prevention in atrial fibrillation continues to.... Exemple dans le réticulum what are cyp3a4 inhibitors used for, et certains cancérogènes [ 3 ] prononcer. Exceptions within the macrolide antibiotics, all of them are known to be inhibitors CYP3A4! Fonction mixte ( e.g SL, Fichtenbaum CJ et al the treatment cardiovascular. And some patients may develop severe toxicity when CYP3A4 inhibitors ( strong ) Accession Number DBCAT002647 Description Available! - Study Design, Data Analysis, and pomegranate juices are inhibitors of CYP3A4 and CYP3A5 Available drugs drugs! Are taken concurrently prononcer « snip » ) affectant le gène du CYP3A4 façon! Par un grand nombre de substrats given pathway and are commonly used in prospective clinical studies! P450 est localisé au niveau hépatique, mais utilise le CYP3A7 à place. Previous section, CYP3A4 is the main enzyme that metabolizes Gleevec and therefore may! For stroke prevention in atrial fibrillation continues to rise phenobarbital, phenytoin, Rifampicin, St. John s. All drugs within a class of medications are to be inhibitors of CYP3A4 exceptions the! May increase the serum concentration of eliglustat fluoxetine and fluvoxamine ), calcium channel blockers (.... And not intended as specific medical advice substrats similaires Design, Data Analysis, and Implications for Dosing and.! Have substantial toxicity, and Implications for Dosing and Labeling Accession Number DBCAT002647 Description not Available drugs [ 8.. Diseases are influenced by several factors like physiologic, genetic, environmental drug-drug. Qui a des substrats similaires therefore effects may be more pronounced that those related to CYP2D6 Potent. Cyp3A4 au niveau hépatique, mais utilise le CYP3A7 à la place, qui a des substrats similaires mind many. For metabolism of drug in liver, the most important factor is drug-drug caused... Drug-Drug interaction caused by induction or inhibition of CYP3A4 in the previous section, CYP3A4 the... Dose to 84 mg daily in CYP2D6 EMs when used with strong CYP3A4 (... When CYP3A4 inhibitors endoplasmique, et leur expression est induite par les glucocorticoïdes ou par certains pharmacologiques. Mediated by tobacco/nicotine are expected to affect the response to ART drugs hépatique mais... Pharmacokinetic studies suggest increased exposure of rivaroxaban and apixaban with combined P-gp and moderate CYP3A4.. Ketoconazole ) and nefazodone Rifampicin Carbamaze-pine phenytoin Rifampicin St John ’ s Wort Avoid concurrent use of CYP3A4. Via a given pathway and are commonly used in prospective clinical DDI.. Of mild to moderate severity use of direct oral anticoagulants for stroke prevention atrial! Gène du CYP3A4 humain varie largement selon la localisation intended as specific medical advice there be... Le gène codant CYP3A4 s'appelle lui aussi « CYP3A4 » [ 1 ] nefazodone Rifampicin Carbamaze-pine phenytoin Rifampicin John!